Oligodendrocyte pathology in Huntington's disease: from mechanisms to therapeutics

Trends Mol Med. 2023 Aug 15:S1471-4914(23)00160-0. doi: 10.1016/j.molmed.2023.07.010. Online ahead of print.ABSTRACTOligodendrocytes (OLGs), highly specialized glial cells that wrap axons with myelin sheaths, are critical for brain development and function. There is new recognition of the role of OLGs in the pathogenesis of neurodegenerative diseases (NDDs), including Huntington's disease (HD), a prototypic NDD caused by a polyglutamine tract expansion in huntingtin (HTT), which results in gain- and loss-of-function effects. Clinically, HD is characterized by a constellation of motor, cognitive, and psychiatric disturbances. White matter (WM) structures, representing myelin-rich regions of the brain, are profoundly affected in HD, and recent findings reveal oligodendroglia dysfunction as an early pathological event. Here, we focus on mechanisms that underlie oligodendroglial deficits and dysmyelination in the progression of the disease, highlighting the pathogenic contributions of mutant HTT (mHTT). We also discuss potential therapeutic implications involving these molecular pathways.PMID:37591764 | DOI:10.1016/j.molmed.2023.07.010
Source: Trends in Molecular Medicine - Category: Molecular Biology Authors: Source Type: research